The Amanta Healthcare IPO has quickly become one of the most talked-about offerings in the market, attracting massive interest from investors across categories.
On the opening day, the IPO witnessed a healthy response, with strong participation from both retail and non-institutional investors. The demand only grew on the second day, pushing total subscriptions into double digits, showing clear confidence in the company’s growth story.
Market watchers note that the Grey Market Premium (GMP) has been holding firm, further signaling investor optimism and expectations of potential listing gains.
The issue, worth ₹126 crore, is a fresh share offer aimed at funding capacity expansion and working capital needs. With this move, Amanta Healthcare is positioning itself for the next phase of growth, building on its established presence in sterile formulations and medical devices.
Key Highlights:
- Issue Size: ₹126 crore via fresh share offer
- Subscription: Robust demand with strong oversubscription by Day 2
- Grey Market Premium (GMP): Holding steady, indicating likely listing gains
- Bidding Window: September 1–3, 2025
- Allotment Date: September 4, 2025
- Tentative Listing: September 8–9, 2025
Investor Takeaway
The Amanta Healthcare IPO has already delivered impressive subscription numbers and a steady premium in the grey market. These early signs highlight strong market confidence. For investors, the IPO represents both an opportunity for potential short-term listing gains and a long-term play in the healthcare manufacturing sector.
Risk Disclaimer
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should carefully evaluate risks, financials, and consult professionals before investing.
